Daniel C. Leslie

Daniel C. Leslie

Auto-generated profile, based on publicly available information

Daniel C. Leslie

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DHDongeun Huh
Dongeun Huh
DLDaniel C. Leslie
Daniel C. Leslie
BMBenjamin D. Matthews
Benjamin D. Matthews
JFJacob P. Fraser
Jacob P. Fraser
SJSamuel Jurek
Samuel Jurek
DIDonald E Ingber
Donald E Ingber
An in vitro model of human pulmonary edema predicts drug toxicity and efficacy previously observed in humans.

12 October 2014 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
DLDaniel C Leslie
Daniel C Leslie
AWAnna Wayerhouse
Anna Wayerhouse
JBJulia B Berthet
Julia B Berthet
TVThomas M Valentin
Thomas M Valentin
AWAlexander L Watters
Alexander L Watters
DIDonald E Ingber
Donald E Ingber

20 February 2015 in Chemistry of Materials
Verified
Journal Article
Closed access
CHCaitlin Howell
Caitlin Howell
TVThy L. Vu
Thy L. Vu
CJChristopher P. Johnson
Christopher P. Johnson
XHXu Hou
Xu Hou
OAOnye Ahanotu
Onye Ahanotu
JAJoanna Aizenberg
Joanna Aizenberg

1 February 2009 in Nature Physics
Verified
Journal Article
Closed access
DLDaniel C. Leslie
Daniel C. Leslie
CEChristopher J. Easley
Christopher J. Easley
ESErkin Seker
Erkin Seker
JKJames M. Karlinsey
James M. Karlinsey
MUMarcel Utz
Marcel Utz
JLJames P. Landers
James P. Landers

22 June 2009 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
CPCarol W. Price
Carol W. Price
DLDaniel C. Leslie
Daniel C. Leslie
JLJames P. Landers
James P. Landers
As recently as the early 1990s, DNA purification was time-consuming, requiring the use of toxic, hazardous reagents. The advent of solid phase extraction techniques and the availability of commercial kits for quick and reliable DNA extraction has relegated those early techniques largely to the history books. High quality DNA can now be extracted from whole blood, serum, saliva, urine, stool, cerebral spinal fluid, tissues, and cells in less time without sacrificing recovery. Having achieved such a radical change in the methodology of DNA extraction, focus has shifted to adapting these methods to a miniaturized system, or “lab-on-a-chip” (A. Manz, N. Graber and H. M. Widmer, Sens. Actuators, B, 1990, 1, 244–248).1 Manz et al.'s concept of a “miniaturized total chemical analysis system” (µTAS) involved a silicon chip that incorporated sample pretreatment, separation and detection.1 This review will focus on the first of these steps, sample pretreatment in the form of DNA purification. The intention of this review is to provide an overview of the fundamentals of nucleic acid purification and solid phase extraction (SPE) and to discuss specific microchip DNA extraction successes and challenges. In order to fully appreciate the advances in DNA purification, a brief review of the history of DNA extraction is provided so that the reader has an understanding of the impact that the development of SPE techniques have had. This review will highlight the different methods of nucleic acid extraction (Table 1), including relevant citations, but without an exhaustive summary of the literature. A recent review by Wen et al. (J. Wen, L. A. Legendre, J. M. Bienvenue and J. P. Landers, Anal. Chem., 2008, 80, 6472–6479)2 covers solid phase extraction methods with a greater focus on their incorporation into integrated microfluidic systems.

19 August 2013 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
KDKarel Domansky
Karel Domansky
DLDaniel C. Leslie
Daniel C. Leslie
JMJames McKinney
James McKinney
JFJacob P. Fraser
Jacob P. Fraser
JSJosiah D. Sliz
Josiah D. Sliz
DIDonald E Ingber
Donald E Ingber
Polydimethylsiloxane (PDMS) has numerous desirable properties for fabricating microfluidic devices, including optical transparency, flexibility, biocompatibility, and fabrication by casting; however, partitioning of small hydrophobic molecules into the bulk of PDMS hinders industrial acceptance of PDMS microfluidic devices for chemical processing and drug development applications. Here we describe an attractive alternative material that is similar to PDMS in terms of optical transparency, flexibility and castability, but that is also resistant to absorption of small hydrophobic molecules.